lactic acid has been researched along with Acidosis, Diabetic in 47 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thiamine functions as an important cofactor in aerobic metabolism and thiamine deficiency can contribute to lactic acidosis." | 7.80 | The relationship between lactate and thiamine levels in patients with diabetic ketoacidosis. ( Berg, K; Donnino, MW; Gautam, S; Giberson, T; Graver, A; Liu, X; Moskowitz, A; Uber, A, 2014) |
| "The objective was to assess glucose, lactate, glycerol, and pyruvate concentrations in the interstitial fluid of the adipose tissue as well as the glucose relative recovery coefficient in reference to capillary blood (RC) during the first two days of the standard treatment of diabetic ketoacidosis (DKA) in patients with type 1 and type 2 diabetes." | 7.79 | Microdialysis monitoring of glucose, lactate, glycerol, and pyruvate in patients with diabetic ketoacidosis. ( Ciechanowska, A; Foltynski, P; Karnafel, W; Kawiak, J; Krzymien, J; Ladyzynski, P; Pulawska, E; Sabalinska, S; Wojcicki, JM, 2013) |
| "Bumetanide treatment increased ATP/Pi and PCr/Pi and ameliorated the declines in these values with insulin/saline treatment." | 5.36 | Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide. ( Anderson, SE; Glaser, N; O'Donnell, ME; Tancredi, DJ; Yuen, N, 2010) |
| "Thiamine functions as an important cofactor in aerobic metabolism and thiamine deficiency can contribute to lactic acidosis." | 3.80 | The relationship between lactate and thiamine levels in patients with diabetic ketoacidosis. ( Berg, K; Donnino, MW; Gautam, S; Giberson, T; Graver, A; Liu, X; Moskowitz, A; Uber, A, 2014) |
| "The objective was to assess glucose, lactate, glycerol, and pyruvate concentrations in the interstitial fluid of the adipose tissue as well as the glucose relative recovery coefficient in reference to capillary blood (RC) during the first two days of the standard treatment of diabetic ketoacidosis (DKA) in patients with type 1 and type 2 diabetes." | 3.79 | Microdialysis monitoring of glucose, lactate, glycerol, and pyruvate in patients with diabetic ketoacidosis. ( Ciechanowska, A; Foltynski, P; Karnafel, W; Kawiak, J; Krzymien, J; Ladyzynski, P; Pulawska, E; Sabalinska, S; Wojcicki, JM, 2013) |
| " We assessed the effect of a novel oral antilipolytic agent, N-[(1S, trans)-2-hydroxycyclopentyl]adenosine (GR 79236), in experimental diabetic ketoacidosis." | 3.69 | Improvement of ketoacidosis in the diabetic rat after the administration of the oral antilipolytic agent GR 79236. ( Mikhailidis, DP; Strong, P; Thompson, CS, 1994) |
| "Measurements were made of lactate, pyruvate and 2,3-diphosphoglycerate in 69 children admitted to the hospital in a state of diabetic ketoacidosis of different intensity." | 3.68 | [Diagnostic value of detection of blood levels of lactate, pyruvate and 2,3-diphosphoglycerate in children with diabetes mellitus]. ( Baturin, AA; Marchenko, LF; Terent'eva, EA, 1991) |
| "Hyperlactatemia was not associated with length of time to DKA resolution and length of hospital stay." | 3.01 | Hyperlactatemia associated with diabetic ketoacidosis in pediatric intensive care unit. ( Li, Y; Liu, J; Yan, H, 2021) |
| "Post mortem diagnosis of glucose metabolism disorders can be difficult and vague because of the lack of characteristic morphological findings." | 2.47 | Disorders of glucose metabolism-post mortem analyses in forensic cases: part I. ( Hess, C; Madea, B; Musshoff, F, 2011) |
| "Hyperlactatemia was associated with in-hospital mortality (Odds Ratio [OR] 1." | 1.91 | Association between elevated lactate and clinical outcomes in adults with diabetic ketoacidosis. ( Doola, R; Kumar, A; Laupland, KB; Ramanan, M; Shaikh, A; Tabah, A; Zahumensky, A, 2023) |
| "We reviewed episodes of diabetic ketoacidosis from 79 diabetes patients (one episode per patient)." | 1.72 | Hyperlactatemia in diabetic ketoacidosis. ( Brooks, GA; Lazar, AA; Masharani, U; Strycker, LA; Wu, K, 2022) |
| "Sixteen children and adolescents with type 1 diabetes (T1D) had blood samples obtained, 6-12 hours into treatment, at three weeks and three months post start of treatment." | 1.56 | Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis ( Artlett, CM; Blum, J; Hoffman, WH; Ikeda, T; Ishikawa, T; Tani, N, 2020) |
| "Diabetic ketoacidosis (DKA), a severe complication of diabetes mellitus with potentially fatal consequences, is characterized by hyperglycemia and metabolic acidosis due to the accumulation of ketone bodies, which requires people with diabetes to monitor both glucose and ketone bodies." | 1.56 | Microneedle-Based Detection of Ketone Bodies along with Glucose and Lactate: Toward Real-Time Continuous Interstitial Fluid Monitoring of Diabetic Ketosis and Ketoacidosis. ( Aghavali, R; Barfidokht, A; Dassau, E; Mercier, PP; Moonla, C; Tangkuaram, T; Tehrani, F; Teymourian, H; Vargas, E; Wang, J, 2020) |
| "Acute kidney injury was categorized into three stages using the Kidney Disease Improving Global Outcomes scale." | 1.51 | Acute Kidney Injury in Critically Ill Children Admitted to the PICU for Diabetic Ketoacidosis. A Retrospective Study. ( Gendler, Y; Kadmon, G; Kaplan, E; Nahum, E; Weissbach, A; Zur, N, 2019) |
| "sixty patients with diabetic ketoacidosis were enrolled in the study; in which 24 (40%) patients were died within 5 days after admission." | 1.40 | Predictors of five days mortality in diabetic ketoacidosis patients: a prospective cohort study. ( Pohan, HT; Sutrisna, B; Suwarto, S; Waspadji, S, 2014) |
| "Diabetes and alcohol abuse may cause severe metabolic disturbances that can be fatal." | 1.39 | Assessment of Traub formula and ketone bodies in cause of death investigations. ( Keltanen, T; Lindroos, K; Palo, JU; Partanen, T; Sajantila, A; Valonen, T, 2013) |
| "A high anion gap in diabetic ketoacidosis (DKA) suggests that some unmeasured anions must contribute to the generation of the anion gap." | 1.37 | Closing the anion gap: contribution of D-lactate to diabetic ketoacidosis. ( Adeli, K; Krahn, J; Lu, J; Meng, QH; Randell, E; Zello, GA, 2011) |
| "Bumetanide treatment increased ATP/Pi and PCr/Pi and ameliorated the declines in these values with insulin/saline treatment." | 1.36 | Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide. ( Anderson, SE; Glaser, N; O'Donnell, ME; Tancredi, DJ; Yuen, N, 2010) |
| "Death was, therefore, due to diabetic ketoacidosis complicated by hypothermia." | 1.36 | Erosive gastritis, Armanni-Ebstein phenomenon and diabetic ketoacidosis. ( Byard, RW; Zhou, C, 2010) |
| "During diabetic ketoacidosis (DKA), serum ketone concentrations markedly increase; however, little is known about whether ketone bodies accumulate in cerebral tissues during DKA." | 1.33 | Detection of cerebral {beta}-hydroxy butyrate, acetoacetate, and lactate on proton MR spectroscopy in children with diabetic ketoacidosis. ( Barnes, PD; Buonocore, MH; Dicarlo, J; Glaser, N; Kuppermann, N; Marcin, J; Neely, EK; Wootton-Gorges, SL, 2005) |
| "Diabetic ketoacidosis (DKA) and alcoholic ketoacidosis (AKA) are two medical emergencies characterized by elevated total ketone body concentration." | 1.31 | Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis. ( Bhoola, SM; DiGirolamo, M; Isaacs, SD; Kokko, JP; Tuvlin, JA; Umpierrez, GE, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (17.02) | 18.7374 |
| 1990's | 6 (12.77) | 18.2507 |
| 2000's | 7 (14.89) | 29.6817 |
| 2010's | 20 (42.55) | 24.3611 |
| 2020's | 6 (12.77) | 2.80 |
| Authors | Studies |
|---|---|
| Masharani, U | 1 |
| Strycker, LA | 1 |
| Lazar, AA | 1 |
| Wu, K | 1 |
| Brooks, GA | 1 |
| Kumar, A | 1 |
| Doola, R | 1 |
| Zahumensky, A | 1 |
| Shaikh, A | 1 |
| Tabah, A | 1 |
| Laupland, KB | 1 |
| Ramanan, M | 1 |
| Hoffman, WH | 1 |
| Ishikawa, T | 1 |
| Blum, J | 1 |
| Tani, N | 1 |
| Ikeda, T | 1 |
| Artlett, CM | 1 |
| Jenei, K | 1 |
| Szatmári, I | 1 |
| Szabó, E | 1 |
| Mariam, A | 1 |
| Luczay, A | 1 |
| Zsidegh, P | 1 |
| Tóth-Heyn, P | 1 |
| Teymourian, H | 1 |
| Moonla, C | 1 |
| Tehrani, F | 1 |
| Vargas, E | 1 |
| Aghavali, R | 1 |
| Barfidokht, A | 1 |
| Tangkuaram, T | 1 |
| Mercier, PP | 1 |
| Dassau, E | 1 |
| Wang, J | 1 |
| Ibrahim, A | 1 |
| Bayramoglu, B | 1 |
| Hokenek, NM | 1 |
| Tekyol, D | 1 |
| Liu, J | 1 |
| Yan, H | 1 |
| Li, Y | 1 |
| Claus, P | 1 |
| Gimenes, AM | 1 |
| Castro, JR | 1 |
| Mantovani, MM | 1 |
| Kanayama, KK | 1 |
| Simões, DMN | 1 |
| Schwartz, DS | 1 |
| Heimer, J | 1 |
| Gascho, D | 1 |
| Chatzaraki, V | 1 |
| Knaute, DF | 1 |
| Sterzik, V | 1 |
| Martinez, RM | 1 |
| Thali, MJ | 1 |
| Zoelch, N | 1 |
| Weissbach, A | 1 |
| Zur, N | 1 |
| Kaplan, E | 1 |
| Kadmon, G | 1 |
| Gendler, Y | 1 |
| Nahum, E | 1 |
| Bo, J | 1 |
| Li, W | 1 |
| Chen, Z | 1 |
| Wadden, DG | 1 |
| Randell, E | 2 |
| Zhou, H | 1 |
| Lu, J | 2 |
| Meng, QH | 2 |
| Moskowitz, A | 1 |
| Graver, A | 1 |
| Giberson, T | 1 |
| Berg, K | 1 |
| Liu, X | 1 |
| Uber, A | 1 |
| Gautam, S | 1 |
| Donnino, MW | 1 |
| Keltanen, T | 1 |
| Sajantila, A | 1 |
| Palo, JU | 1 |
| Partanen, T | 1 |
| Valonen, T | 1 |
| Lindroos, K | 1 |
| Ciechanowska, A | 1 |
| Ladyzynski, P | 1 |
| Wojcicki, JM | 1 |
| Sabalinska, S | 1 |
| Krzymien, J | 1 |
| Pulawska, E | 1 |
| Karnafel, W | 1 |
| Foltynski, P | 1 |
| Kawiak, J | 1 |
| Suwarto, S | 1 |
| Sutrisna, B | 1 |
| Waspadji, S | 1 |
| Pohan, HT | 1 |
| Hess, C | 2 |
| Stockhausen, S | 1 |
| Kernbach-Wighton, G | 1 |
| Madea, B | 2 |
| Love, IY | 1 |
| Perl, S | 1 |
| Rapoport, MJ | 1 |
| Glaser, N | 3 |
| Yuen, N | 2 |
| Anderson, SE | 1 |
| Tancredi, DJ | 1 |
| O'Donnell, ME | 1 |
| Byard, RW | 1 |
| Zhou, C | 1 |
| Titov, VN | 1 |
| Dmitriev, LF | 1 |
| Krylin, VA | 1 |
| Dmitriev, VA | 1 |
| Musshoff, F | 1 |
| Zello, GA | 1 |
| Adeli, K | 1 |
| Krahn, J | 1 |
| Wetter, J | 1 |
| Gohlke, BC | 1 |
| Woelfle, JF | 1 |
| Palmiere, C | 1 |
| Sporkert, F | 1 |
| Vaucher, P | 1 |
| Werner, D | 1 |
| Bardy, D | 1 |
| Rey, F | 1 |
| Lardi, C | 1 |
| Brunel, C | 1 |
| Augsburger, M | 1 |
| Mangin, P | 1 |
| Ngo, C | 1 |
| Anderson, S | 1 |
| Trifu, A | 1 |
| O'Donnell, M | 1 |
| Shimizu, I | 1 |
| Ishikawa, E | 1 |
| Fukuda, T | 1 |
| Okazaki, S | 1 |
| Jager, AV | 1 |
| Tavares, MF | 1 |
| Shahi, SK | 1 |
| Ranga, S | 1 |
| Arulselvi, S | 1 |
| EWY, GA | 1 |
| PABICO, RC | 1 |
| MAHER, JF | 1 |
| MINTZ, DH | 1 |
| MENGIS, CL | 1 |
| Wootton-Gorges, SL | 1 |
| Buonocore, MH | 1 |
| Kuppermann, N | 1 |
| Marcin, J | 1 |
| Dicarlo, J | 1 |
| Neely, EK | 1 |
| Barnes, PD | 1 |
| Osuna, E | 1 |
| Vivero, G | 1 |
| Conejero, J | 1 |
| Abenza, JM | 1 |
| Martínez, P | 1 |
| Luna, A | 1 |
| Pérez-Cárceles, MD | 1 |
| Ogihara, T | 1 |
| Tanaka, Y | 1 |
| Funk, GC | 1 |
| Jiang, GY | 1 |
| Geng, DZ | 1 |
| Tripathy, BB | 1 |
| Garabadu, NK | 1 |
| Samal, KC | 1 |
| Christopher, MM | 1 |
| Broussard, JD | 1 |
| Fallin, CW | 1 |
| Drost, NJ | 1 |
| Peterson, ME | 1 |
| Thompson, CS | 1 |
| Strong, P | 1 |
| Mikhailidis, DP | 1 |
| Pepper, GM | 1 |
| Schwartz, M | 1 |
| Umpierrez, GE | 1 |
| DiGirolamo, M | 1 |
| Tuvlin, JA | 1 |
| Isaacs, SD | 1 |
| Bhoola, SM | 1 |
| Kokko, JP | 1 |
| Kawanishi, K | 1 |
| Ishida, T | 1 |
| Marchenko, LF | 1 |
| Baturin, AA | 1 |
| Terent'eva, EA | 1 |
| Ritz, S | 1 |
| Kaatsch, HJ | 1 |
| Fulop, M | 1 |
| Bock, J | 1 |
| Ben-Ezra, J | 1 |
| Antony, M | 1 |
| Danzig, J | 1 |
| Gage, JS | 1 |
| Kosugi, K | 1 |
| Scofield, RF | 1 |
| Chandramouli, V | 1 |
| Kumaran, K | 1 |
| Schumann, WC | 1 |
| Landau, BR | 1 |
| Yang, DP | 1 |
| Liang, JZ | 1 |
| Luo, ZT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults[NCT03520569] | Early Phase 1 | 15 participants (Actual) | Interventional | 2019-02-04 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The augmentation index (AIx) measured at the radial artery is a measure of systemic arterial stiffness, and is defined as the ratio of augmentation (Δ P) to central pulse pressure and expressed as percent. AIx = (ΔP/PP) x 100, where P = pressure and PP = Pulse Pressure. Higher percentages indicate increased arterial stiffness. (NCT03520569)
Timeframe: baseline and after 2 hour insulin clamp
| Intervention | percentage (Mean) |
|---|---|
| Octreotide- Euglycemia | -4.15 |
| Octreotide - Euglycemia- Insulin Clamp | -2.23 |
| Octreotide- Hyperglycemia | -4.80 |
| Octreotide- Hyperglycemia - Insulin Clamp | -8.45 |
Flow mediated dilation measures the change in brachial diameter in response to 5 minutes of ischemia using B-mode ultrasound. It provides an index of nitric oxide generation by the endothelium . (NCT03520569)
Timeframe: baseline and after 2 hour insulin clamp
| Intervention | % change (Mean) |
|---|---|
| Octreotide- Euglycemia | 11.8 |
| Octreotide - Euglycemia- Insulin Clamp | 11.8 |
| Octreotide- Hyperglycemia | 8.9 |
| Octreotide- Hyperglycemia - Insulin Clamp | 8.95 |
The time required for a blood pressure wave to travel from the carotid to the femoral artery was measured in meter/sec. This is a measurement of central artery stiffness. Higher numbers indicate stiffer vessels (NCT03520569)
Timeframe: baseline and after 2 hour insulin clamp
| Intervention | m/sec (Mean) |
|---|---|
| Octreotide- Euglycemia | 5.21 |
| Octreotide - Euglycemia- Insulin Clamp | 5.06 |
| Octreotide- Hyperglycemia | 4.79 |
| Octreotide- Hyperglycemia - Insulin Clamp | 5.07 |
3 reviews available for lactic acid and Acidosis, Diabetic
| Article | Year |
|---|---|
Disorders of glucose metabolism-post mortem analyses in forensic cases: part I.
Topics: Blood Proteins; Diabetes Mellitus; Diabetic Ketoacidosis; Forensic Pathology; Fructosamine; Glucose; | 2011 |
[Diabetic lactic acidosis].
Topics: Acidosis, Lactic; Contraindications; Diabetic Ketoacidosis; Humans; Hypoglycemic Agents; Insulin; La | 2006 |
[Stewart's acid-base approach].
Topics: Acid-Base Equilibrium; Acidosis; Alkalosis; Anions; Bicarbonates; Cations; Diabetic Ketoacidosis; El | 2007 |
1 trial available for lactic acid and Acidosis, Diabetic
| Article | Year |
|---|---|
Hyperlactatemia associated with diabetic ketoacidosis in pediatric intensive care unit.
Topics: Biomarkers; Child; Diabetic Ketoacidosis; Female; Follow-Up Studies; Humans; Hyperlactatemia; Intens | 2021 |
43 other studies available for lactic acid and Acidosis, Diabetic
| Article | Year |
|---|---|
Hyperlactatemia in diabetic ketoacidosis.
Topics: 3-Hydroxybutyric Acid; Blood Glucose; Diabetes Mellitus; Diabetic Ketoacidosis; Humans; Hyperglycemi | 2022 |
Association between elevated lactate and clinical outcomes in adults with diabetic ketoacidosis.
Topics: Adult; Cohort Studies; Diabetes Mellitus; Diabetic Ketoacidosis; Humans; Hyperlactatemia; Intensive | 2023 |
Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis
Topics: Adolescent; Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Glycation End Products, | 2020 |
[Changes of lactate levels in diabetic ketoacidosis and in newly diagnosed type 1 diabetes mellitus].
Topics: Blood Gas Analysis; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Femal | 2019 |
Microneedle-Based Detection of Ketone Bodies along with Glucose and Lactate: Toward Real-Time Continuous Interstitial Fluid Monitoring of Diabetic Ketosis and Ketoacidosis.
Topics: Biosensing Techniques; Blood Glucose Self-Monitoring; Diabetic Ketoacidosis; Electrochemical Techniq | 2020 |
Lactate clearance during the first 2 hours after hospital admission: A useful biomarker for predicting 30-day mortality in patients with diabetic ketoacidosis.
Topics: Biomarkers; Cohort Studies; Diabetic Ketoacidosis; Hospitals; Humans; Lactic Acid; Retrospective Stu | 2021 |
Blood lactate concentration in diabetic dogs.
Topics: Animals; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Dog Diseases; Do | 2017 |
Postmortem
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Acetone; Adult; Diabetic Ketoacidosis; Glucose; Humans; Ketone | 2018 |
Acute Kidney Injury in Critically Ill Children Admitted to the PICU for Diabetic Ketoacidosis. A Retrospective Study.
Topics: Acute Kidney Injury; Adolescent; Blood Glucose; Child; Child, Preschool; Critical Illness; Diabetic | 2019 |
D-lactate: a novel contributor to metabolic acidosis and high anion gap in diabetic ketoacidosis.
Topics: Acid-Base Equilibrium; Diabetic Ketoacidosis; Humans; Lactic Acid; Prognosis | 2013 |
The relationship between lactate and thiamine levels in patients with diabetic ketoacidosis.
Topics: Acidosis, Lactic; Adult; Comorbidity; Diabetic Ketoacidosis; Female; Humans; Lactic Acid; Male; Midd | 2014 |
Assessment of Traub formula and ketone bodies in cause of death investigations.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Acetone; Alcoholism; Algorithms; Autopsy; Biomarkers; Blood Gl | 2013 |
Microdialysis monitoring of glucose, lactate, glycerol, and pyruvate in patients with diabetic ketoacidosis.
Topics: Adipose Tissue; Adult; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus | 2013 |
Predictors of five days mortality in diabetic ketoacidosis patients: a prospective cohort study.
Topics: Acid-Base Equilibrium; Adult; Aged; Bicarbonates; Blood Glucose; Coma; Diabetic Ketoacidosis; Female | 2014 |
Death due to diabetic ketoacidosis: Induction by the consumption of synthetic cannabinoids?
Topics: Acetone; Adult; Cannabinoids; Designer Drugs; Diabetic Ketoacidosis; Fatal Outcome; Forensic Toxicol | 2015 |
A Rare Case of Caffeine Storm due to Excessive Coca-Cola Consumption.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Diabetic Ketoacidosis; Diagnosis, Differential; | 2016 |
Cerebral metabolic alterations in rats with diabetic ketoacidosis: effects of treatment with insulin and intravenous fluids and effects of bumetanide.
Topics: Animals; Aspartic Acid; Brain; Brain Edema; Bumetanide; Cerebrovascular Circulation; Creatinine; Dia | 2010 |
Erosive gastritis, Armanni-Ebstein phenomenon and diabetic ketoacidosis.
Topics: 3-Hydroxybutyric Acid; Adult; Autopsy; Diabetic Ketoacidosis; Fatal Outcome; Gastritis; Glucose; Hum | 2010 |
[Methylglyoxal--a test for impaired biological functions of exotrophy and endoecology, low glucose level in the cytosol and gluconeogenesis from fatty acids (a lecture)].
Topics: Animals; Cytosol; Diabetes Mellitus; Diabetic Ketoacidosis; Energy Metabolism; Fatty Acids; Gluconeo | 2010 |
Closing the anion gap: contribution of D-lactate to diabetic ketoacidosis.
Topics: 3-Hydroxybutyric Acid; Bicarbonates; Blood Glucose; Diabetic Ketoacidosis; Female; Humans; Lactic Ac | 2011 |
Hyperglycemic hyperosmolar state as initial manifestation of pediatric insulin-dependent diabetes.
Topics: Autoantibodies; Blood Glucose; Child, Preschool; Combined Modality Therapy; Creatine; Diabetes Melli | 2012 |
Is the formula of Traub still up to date in antemortem blood glucose level estimation?
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Acetone; Blood Glucose; Diabetic Ketoacidosis; Female; Forensi | 2012 |
Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution, and cerebral metabolism.
Topics: Adenosine Triphosphate; Animals; Aspartic Acid; Brain Edema; Cerebrum; Diabetes Mellitus, Experiment | 2012 |
[Blood glucose, urinary glucose, blood ketone bodies, urine ketone bodies, blood lactic acid, and blood pyruvic acid].
Topics: Blood Glucose; Diabetes Mellitus; Diabetic Ketoacidosis; Female; Glycosuria; Humans; Ketone Bodies; | 2012 |
Evaluation of diabetic ketoacidosis-related ionic metabolites in human blood serum by capillary electrophoresis.
Topics: Diabetic Ketoacidosis; Electrolytes; Electrophoresis, Capillary; Humans; Ions; Keto Acids; Lactic Ac | 2003 |
Lactate--a diagnostic indicator.
Topics: Acidosis; Diabetic Ketoacidosis; Energy Metabolism; Humans; Lactic Acid | 2002 |
LACTATE ACIDOSIS ASSOCIATED WITH PHENFORMIN THERAPY AND LOCALIZED TISSUE HYPOXIA. REPORT OF A CASE TREATED BY HEMODIALYSIS.
Topics: Acidosis; Black People; Diabetes Mellitus; Diabetic Ketoacidosis; Humans; Ischemia; Kidney; Kidneys, | 1963 |
LACTIC ACID ACIDEMIA AND PHENFORMIN.
Topics: Acidosis; Acidosis, Lactic; Blood; Diabetes Mellitus; Diabetic Ketoacidosis; Humans; Lactates; Lacti | 1964 |
Detection of cerebral {beta}-hydroxy butyrate, acetoacetate, and lactate on proton MR spectroscopy in children with diabetic ketoacidosis.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Child; Diabetic Ketoacidosis; Female; Humans; Lactic Acid; Mag | 2005 |
Postmortem vitreous humor beta-hydroxybutyrate: its utility for the postmortem interpretation of diabetes mellitus.
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Cadaver; Diabetic Ket | 2005 |
[Treatment of diabetic lactic acidosis].
Topics: Diabetic Ketoacidosis; Humans; Lactates; Lactic Acid | 1984 |
[Report of 3 cases of diabetes complicated by lactic acidosis].
Topics: Aged; Diabetic Ketoacidosis; Female; Humans; Lactates; Lactic Acid; Male; Middle Aged | 1984 |
Phenformin and other antidiabetic drugs on blood lactic acid.
Topics: Adolescent; Adult; Aged; Child; Diabetic Ketoacidosis; Female; Humans; Hypoglycemic Agents; India; L | 1984 |
Increased serum D-lactate associated with diabetic ketoacidosis.
Topics: 3-Hydroxybutyric Acid; Animals; Blood Glucose; Cats; Diabetic Ketoacidosis; Hydroxybutyrates; Lactat | 1995 |
Improvement of ketoacidosis in the diabetic rat after the administration of the oral antilipolytic agent GR 79236.
Topics: Adenosine; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Fatty Aci | 1994 |
Lactic acidosis associated with Glucophage use in a man with normal renal and hepatic function.
Topics: Acidosis, Lactic; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Drug Therapy, Combination; Human | 1997 |
Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis.
Topics: Adult; Alcoholism; Blood Glucose; Diabetic Ketoacidosis; Diagnosis, Differential; Epinephrine; Femal | 2000 |
[Lactic acidosis inpatients with diabetes mellitus].
Topics: Acidosis, Lactic; Adolescent; Adult; Aged; Bicarbonates; Blood Glucose; Diabetic Ketoacidosis; Dichl | 1991 |
[Diagnostic value of detection of blood levels of lactate, pyruvate and 2,3-diphosphoglycerate in children with diabetes mellitus].
Topics: 2,3-Diphosphoglycerate; Adolescent; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Com | 1991 |
[Postmortem diagnosis of fatal diabetic metabolic dyscontrol: what is the significance of cerebrospinal fluid and vitreous body total values and HbA1?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Blood-Brain Barrier; Blood-Retinal Barrie | 1990 |
Plasma lactate and 3-hydroxybutyrate levels in patients with acute ethanol intoxication.
Topics: 3-Hydroxybutyric Acid; Acute Disease; Adult; Aged; Alcoholic Intoxication; Blood Glucose; Diabetic K | 1986 |
Pathways of acetone's metabolism in the rat.
Topics: Acetone; Acetyl Coenzyme A; Animals; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Female; | 1986 |
[Alteration of blood lactic acid levels in biguanide therapy in diabetics].
Topics: Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Humans; Lactates; Lacti | 1985 |